Biologic Drugs

Mar 26, 2018
By Pharmaceutical Technology Editors
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
Mar 26, 2018
By Pharmaceutical Technology Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By Pharmaceutical Technology Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By Pharmaceutical Technology Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 19, 2018
By Pharmaceutical Technology Editors
Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.
Mar 08, 2018
By Pharmaceutical Technology Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Mar 08, 2018
By Pharmaceutical Technology Editors
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Mar 06, 2018
By Pharmaceutical Technology Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 20, 2018
By Pharmaceutical Technology Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 13, 2018
By Pharmaceutical Technology Editors
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.
native1_300x100
lorem ipsum